Showing results for "Vanda Pharma"
markets
S&P 500 Companies Adjust GAAP Net Income for More Items, Boost EPSLarge US companies are bolstering their adjusted earnings per share by excluding items such as litigation expenses and amortization of intangible assets from their net income, even as regulators scrutinize such practices, a new analysis finds.May 22, 2024
industries
Weight-Loss Upstart Viking (VKTX) Needs Deal to Vie With Lilly, Novo (LLY, NVO)Hope for a weight-loss drug that’s better than Ozempic and Wegovy has sent Viking Therapeutics Inc. shares skyrocketing. But to reach the next level the biopharmaceutical developer likely needs a partner — or a buyer.May 22, 2024
markets
The Growing Popularity of Compounded Weight-Loss DrugsZach Reitano, Ro CEO, explains what is driving the growing interest for weight-loss drugs and the struggle major pharmaceutical companies are experiencing keeping up with demand. He joins David Westin on "Wall Street Week" daily. (Source: Bloomberg)May 21, 2024
industries
Nestlé Targets People on GLP-1 Drugs With Launch of Frozen PizzaNestlé SA is launching a new line of frozen foods specifically targeting users of GLP-1 drugs like Ozempic and Mounjaro, pouncing on a weight-loss drug craze that is changing eating habits and impacting industries spanning retailers to airlines.May 21, 2024